{
    "2021-08-29": [
        [
            {
                "time": "",
                "original_text": "西南证券维持天坛生物买入评级：上半年业绩稳健增长，浆站获批节奏加快",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "买入评级",
                        "业绩稳健增长",
                        "浆站获批",
                        "节奏加快"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "天坛生物(600161)2021年中报点评：采浆稳步提升 终端持续拓展",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "2021年中报",
                        "采浆稳步提升",
                        "终端持续拓展"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}